4.2 Article

Identifying population-level indicators to measure the quality of cancer care for women

期刊

出版社

OXFORD UNIV PRESS
DOI: 10.1093/intqhc/mzr043

关键词

quality indicators; cancer; women's health; equity; modified Delphi panel

资金

  1. Echo: Improving Women's Health in Ontario
  2. Ontario Ministry of Health and Long-Term Care (MOHLTC)
  3. Institute for Clinical Evaluative Sciences (ICES)

向作者/读者索取更多资源

Objective. Although there is interest in measuring the quality of cancer care, there has been limited effort to evaluate quality for specific subpopulations such as women or to examine differences in performance among women associated with sociodemographic characteristics. The objective of this study was to identify a comprehensive set of quality indicators for evaluation of the quality of cancer care received by women using administrative data. Design. A conceptual measurement framework developed by the study investigators was used to guide literature review to identify existing quality indicators. The list of potential indicators from the literature was first reviewed by the study investigators with respect to importance and feasibility to determine a set of indicators to present to an expert panel who used a modified Delphi process to select indicators for inclusion using predetermined explicit criteria. Setting. The Project for an Ontario Women's Health Evidence-Based Report Card. Participants. A multidisciplinary expert panel consisting of clinicians, researchers and administrators with expertise in cancer, quality of care and/or health services research. Main Outcome Measure. Set of quality indicators evaluable from administrative data. Results. The initial literature search identified 427 indicators, of which 46 were rated as important and feasible by the study investigators. Following two rounds of ratings and an in-person meeting, the expert panel recommended 31 indicators for inclusion in the final set spanning the following areas: general indicators (three indicators), cancer screening (six), colorectal cancer (four), lung cancer (three), breast cancer (five), gynecologic cancers (five), and end-of-life care (five). Conclusions. A comprehensive set of 31 indicators was identified to evaluate the quality of cancer care received by women that also allows assessment of gender and socioeconomic disparities in cancer care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data

Jacques Raphael, Lucie Richard, Melody Lam, Phillip S. Blanchette, Natasha B. Leighl, George Rodrigues, Maureen E. Trudeau, Monika K. Krzyzanowska

Summary: This study used provincial administrative health data to estimate the proportion of patients with advanced cancer for which IO had been approved received the treatment and explored factors associated with IO use.

ONCOLOGIST (2022)

Article Endocrinology & Metabolism

Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers

Lucy X. Ma, Osvaldo Espin-Garcia, Philippe L. Bedard, Tracy Stockley, Rebecca Prince, Ozgur Mete, Monika K. Krzyzanowska

Summary: This study analyzes the actionability and clinical use of NGS results in advanced thyroid cancer. Most patients had at least one potentially actionable mutation and 57% of patients had at least one Level 1 or 2 alteration, predominantly driven by BRAF V600E and RET alterations. This study rationalizes the need for routine multigene NGS testing or reflex BRAF and RET testing in the management of patients with advanced thyroid cancer.

THYROID (2022)

Review Oncology

Implementation and Impact of Choosing Wisely Recommendations in Oncology

Sonieya Nagarajah, Melanie Lynn Powis, Rouhi Fazelzad, Monika K. Krzyzanowska, Vishal Kukreti

Summary: This study systematically reviewed the uptake of oncology-specific Choosing Wisely recommendations and found that most articles reported passive changes in adherence after the publication of the recommendations. Active implementation strategies, such as provider education and stakeholder engagement, were associated with improved compliance. However, the uptake of oncology-specific Choosing Wisely recommendations remains limited, indicating a need for more attention and support for active implementation.

JCO ONCOLOGY PRACTICE (2022)

Meeting Abstract Oncology

Early mortality in patients with cancer treated with immunotherapy in routine practice

J. Raphael, L. Richard, M. Lam, P. Blanchette, N. Leighl, G. Rodrigues, M. E. Trudeau, M. K. Krzyzanowska

ANNALS OF ONCOLOGY (2022)

Article Oncology

Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer

Melanie Powis, Rinku Sutradhar, Aditi Patrikar, Matthew Cheung, Inna Gong, Abi Vijenthira, Lisa K. Hicks, Drew Wilton, Monika K. Krzyzanowska, Simron Singh

Summary: A population-based study in Ontario, Canada found that cancer patients who were recent or nonrecent immigrants and marginalized individuals had lower rates of COVID-19 vaccination. This difference is likely due to the interplay between systemic barriers to access and cultural or social influences.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

The development of an electronic geriatric assessment tool: Comprehensive health assessment for my plan (CHAMP)

Simon Cook, Cosmin Munteanu, Efthymios Papadopoulos, Howard Abrams, Jennifer N. Stinson, Eric Pitters, Douglas Stephens, Margaret Lumchick, Urban Emmenegger, Rama Koneru, Janet Papadakos, Armin Shahrokni, Sara Durbano, Ines Menjak, Rajin Mehta, Kristen Haase, Raymond Jang, Monika K. Krzyzanowska, Craig Dale, Jennifer Jones, Manon Lemonde, Shabbir Alibhai, Martine Puts

Summary: Researchers developed a self-reported electronic geriatric assessment tool called CHAMP to improve feasibility and accuracy of assessment and treatment decision making for older adults with cancer. The tool was tested and approved by both older adults and oncology clinicians. The CHAMP tool includes questions and recommendations in various health domains.

JOURNAL OF GERIATRIC ONCOLOGY (2023)

Article Oncology

Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation

Milothy Parthipan, Gregory Feng, Nelly Toledano, Valentina Donison, Henriette Breunis, Abirami Sudharshan, Urban Emmenegger, Antonio Finelli, Padraig Warde, Enrique Soto-Perez-de-Celis, Monika Krzyzanowska, Andrew Matthew, Hance Clarke, Daniel Santa Mina, Shabbir M. H. Alibhai, Martine Puts

Summary: Studying the symptom experiences of older men with metastatic prostate cancer during treatment can help identify unmet supportive care needs and improve patient wellbeing. Previous research has focused on the psychological experience rather than the overall symptom experience. The objective of this study was to understand the lived experience of symptoms and supportive care needs in older men undergoing treatment for metastatic prostate cancer.

JOURNAL OF GERIATRIC ONCOLOGY (2023)

Article Oncology

Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C Trial

Martine Puts, Naser Alqurini, Fay Strohschein, Rama Koneru, Ewa Szumacher, Caroline Mariano, Johanne Monette, Tina Hsu, Sarah Brennenstuhl, Bianca McLean, Aria Wills, Arielle Berger, Eitan Amir, Lindy Romanovsky, Anson Li, Rajin Mehta, Monika Krzyzanowska, Christine Elser, Raymond Jang, Anca Prica, Doreen Wan-Chow-Wah, Eric Pitters, Urban Emmenegger, Ines B. Menjak, Simon Bergman, Manon Lemonde, Henriette Breunis, Francois Beland, Shabbir M. H. Alibhai

Summary: The American Society of Clinical Oncology recommends geriatric assessment and management for older adults with cancer considering chemotherapy, but there is limited evidence on its impact on quality of life.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day

Matthew H. Taylor, Sophie Leboulleux, Yury Panaseykin, Bhavana Konda, Christelle de la Fouchardiere, Brett G. M. Hughes, Andrew G. Gianoukakis, Young Joo Park, Ilia Romanov, Monika K. Krzyzanowska, Diana Garbinsky, Bintu Sherif, Jie Janice Pan, Terri A. Binder, Nicholas Sauter, Ran Xie, Marcia S. Brose

Summary: In this study comparing the starting dose of lenvatinib 18 mg/day with 24 mg/day in RR-DTC patients, no significant difference was found in the health-related quality of life (HRQoL). These findings support the use of the approved lenvatinib starting dose of 24 mg/day in RR-DTC patients.

CANCER MEDICINE (2023)

Article Oncology

Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study

Camilla Zimmermann, Ashley Pope, Breffni Hannon, Philippe L. Bedard, Gary Rodin, Neesha Dhani, Madeline Li, Leonie Herx, Monika K. Krzyzanowska, Doris Howell, Jennifer J. Knox, Natasha B. Leighl, Srikala Sridhar, Amit M. Oza, Stephanie Lheureux, Christopher M. Booth, Geoffrey Liu, Jacqueline Alcalde Castro, Nadia Swami, Rachel Sue-A-Quan, Anne Rydall, Lisa W. Le

Summary: This study reports preliminary findings of a mixed methods study involving a randomized controlled trial (RCT) of Symptom screening with Targeted Early Palliative care (STEP) and qualitative interviews. The results showed that STEP was more effective in providing palliative care and improving patient-reported outcomes of quality of life, symptom control, and satisfaction with care compared to usual care.

SUPPORTIVE CARE IN CANCER (2023)

Article Oncology

Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: A population-based cohort study

Rui Fu, Rinku Sutradhar, Qing Li, Pabiththa Kamalraj, Anna Dare, Timothy P. Hanna, Kelvin K. W. Chan, Jonathan C. Irish, Natalie Coburn, Julie Hallet, Simron Singh, Ambica Parmar, Craig C. Earle, Lauren Lapointe-Shaw, Monika K. Krzyzanowska, Alexander V. Louie, Alyson Mahar, David R. Urbach, Daniel I. McIsaac, Danny Enepekides, David Gomez, Nicole J. Look Hong, Jill Tinmouth, Antoine Eskander

Summary: This study investigated the association between the COVID-19 pandemic and early survival among newly diagnosed cancer patients. It found that there was no difference in one-year overall survival between patients diagnosed during the pandemic and those diagnosed in the previous two years. This study highlights the complex impact of the COVID-19 pandemic on cancer care.

CANCER MEDICINE (2023)

Article Oncology

Impact of a Training Program on Oncology Nurses' Confidence in the Provision of Self-Management Support and 5As Behavioral Counseling Skills

Doris Howell, Patrick McGowan, Denise Bryant-Lukosius, Ryan Kirkby, Melanie Powis, Diana Sherifali, Vishal Kukreti, Sara Rask, Monica K. Krzyzanowska

Summary: This paper describes a training program that improved oncology nurses' confidence in providing self-management support to cancer patients. However, further testing in a larger population of nurses is needed to evaluate its effects on nurses' skills and patient outcomes.

CANCERS (2023)

Review Health Care Sciences & Services

Promoting Self-management and Patient Activation Through eHealth: Protocol for a Systematic Literature Review and Meta-analysis

Saeed Moradian, Roma Maguire, Geoffrey Liu, Monika K. Krzyzanowska, Marcus Butler, Chantal Cheung, Marisa Signorile, Nancy Gregorio, Shiva Ghasemi, Doris Howell

Summary: Advances in cancer treatment have led to longer survival for patients, but they still face physical and psychological symptoms. This systematic review aims to assess the effectiveness of eHealth interventions in supporting cancer patients in managing symptoms and improving their quality of life.

JMIR RESEARCH PROTOCOLS (2023)

Letter Oncology

Reply to F. Poizeau et al

Lawson Eng, Rinku Sutradhar, Monika K. Krzyzanowska

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

COVID-19 and Cancer Patients in the Second Year of the Pandemic: Investigating Treatment Impact, Information Sources, and COVID-19-Related Knowledge, Attitudes and Practices

Mohamed A. Ugas, Lisa Avery, Yanning Wang, Alejandro Berlin, Meredith E. Giuliani, Monika Krzyzanowska, Tina J. Papadakos, Naa Kwarley (Linda) Quartey, Diana Samoil, Janet K. Papadakos

Summary: This study examines the impact of the COVID-19 pandemic on the treatment, psychology, knowledge, attitudes, and practices of cancer patients. The results show that most participants did not experience treatment delays and vaccination rates were high. Non-white participants and those who referred to journal articles for information reported higher psychological impact scores.

CURRENT ONCOLOGY (2022)

暂无数据